𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The effect of three dose levels of ICS 205–930 (a selective 5HT-3 antagonist) on cisplatin-induced nausea and vomiting

✍ Scribed by Seinen, Harry; Zonnenberg, Bernard A.; Tjia, Paofi; Neijt, Jean P.

Book ID
122994561
Publisher
Elsevier Science
Year
1989
Weight
264 KB
Volume
25
Category
Article
ISSN
0277-5379

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

High versus low dose granisetron, a sele
High versus low dose granisetron, a selective 5HT3antagonist, for the prevention of chemotherapy-induced nausea and vomiting
✍ H. C. Falkson; C. I. Falkson; G. Falkson 📂 Article 📅 1990 🏛 Springer US 🌐 English ⚖ 173 KB

Fifty six patients, with histologically confirmed cancer, who received highly emetogenic chemotherapy, were entered on a randomized double blind, low versus high dose, study of granisetron, a 5HT3 receptor antagonist. A single dose of intravenous granisetron protected the majority of patients from n

GR38032F, a 5HT3receptor antagonist, in
GR38032F, a 5HT3receptor antagonist, in the prophylaxis of acute cisplatin-induced nausea and vomiting
✍ Michel Marty; Jean P. Droz; Pierre Pouillart; Bernard Paule; Nils Brion; Jacques 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 330 KB

A total of 28 patients receiving cancer chemotherapy with cisplatin-containing regimens (70-120 mg/ m 2) participated in an evaluation of the efficacy and safety of GR38032F for the prevention of acute nausea and vomiting. GR38032F, a 5HT3 receptor antagonist, was given 30 min prior to cisplatin as